Myles W. Jackson
- Published in print:
- 2015
- Published Online:
- September 2015
- ISBN:
- 9780262028660
- eISBN:
- 9780262327190
- Item type:
- chapter
- Publisher:
- The MIT Press
- DOI:
- 10.7551/mitpress/9780262028660.003.0003
- Subject:
- History, History of Science, Technology, and Medicine
This chapter traces the CCR5 gene’s intellectual property lineage. It discusses how genes became patentable in the United States by offering a history of patent law, particularly cases that have been ...
More
This chapter traces the CCR5 gene’s intellectual property lineage. It discusses how genes became patentable in the United States by offering a history of patent law, particularly cases that have been cited as precedents for gene patenting. One of those cases, known as the “adrenalin patent”, was upheld by Judge Learned Hand in 1911 with a view to assist US pharmaceutical companies against their German rivals. Many argue that genes are not patent eligible due to the so-called product-of-nature doctrine. It turns out that the history of patenting products of nature is convoluted, and those who wish to unearth a clear trajectory or stance will be disappointed.Less
This chapter traces the CCR5 gene’s intellectual property lineage. It discusses how genes became patentable in the United States by offering a history of patent law, particularly cases that have been cited as precedents for gene patenting. One of those cases, known as the “adrenalin patent”, was upheld by Judge Learned Hand in 1911 with a view to assist US pharmaceutical companies against their German rivals. Many argue that genes are not patent eligible due to the so-called product-of-nature doctrine. It turns out that the history of patenting products of nature is convoluted, and those who wish to unearth a clear trajectory or stance will be disappointed.